CBS News
567
4.12

Dr. Deborah Birx responds to latest study on risks of hydroxycholoquine for COVID-19

White House coronavirus coordinator Dr. Deborah Birx was asked Friday about results of a new study showing COVID-19 patients got no benefit and suffered some serious side effects from the malaria drug President Trump has pushed as a possible treatment. She noted that many of those patients had other health issues. Watch her remarks.

Watch video on channel "CBS News"

By continuing to browse World News (UAZMI), you acknowledge that you have read the Terms of Use and agree to the use of cookies